Likewise, the FGFR3 was found to be involved in the bladder cancer (hsa05219), MicroRNAs in cancer (hsa05206), EGFR tyrosine kinase inhibitor resistance (hsa01521), MAPK signaling pathway (hsa04010), Ras signaling pathway (hsa04014), Rap1 signaling pathway (hsa04015), calcium signaling pathway (hsa04020), PI3K-Akt signaling pathway (hsa04151), signaling pathways regulating pluripotency of stem cells (hsa04550), pathways in cancer (hsa05200), and central carbon metabolism in cancer (hsa05230). This evidence concerns the gene FGFR3 and urinary bladder carcinoma.